Filing Details

Accession Number:
0001181431-12-031766
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-22 19:21:58
Reporting Period:
2012-05-18
Filing Date:
2012-05-22
Accepted Time:
2012-05-22 18:21:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1323885 Atricure Inc. ATRC Surgical & Medical Instruments & Apparatus (3841) 341940305
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1336087 J David Drachman 6217 Centre Park Drive
West Chester OH 45069
President, Ceo And Director Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-18 5,343 $1.33 497,609 No 4 M Direct
Common Stock Disposition 2012-05-18 5,343 $8.19 492,266 No 4 S Direct
Common Stock Disposition 2012-05-22 33,841 $8.24 458,425 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2012-05-18 5,343 $0.00 5,343 $1.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
24,553 2003-10-14 2012-10-14 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $8.10 to $8.29 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. The Reporting Person intends to apply proceeds from the disposition of these shares to the payment of taxes and other costs incurred in connection with the exercise of options reported separately.
  3. This transaction was executed in multiple trades at prices ranging from $8.20 to $8.40 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. These options were granted on October 14, 2002 and are exercisable cumulatively at a rate of 25% per annum beginning on October 14, 2003 (one year from grant date).